adebrelimab

Synonyms: Arelili® | Ariely® | HTI-1088 | HTI1088 | SHR-1316 | SHR1316

adebrelimab is an approved drug (China NMPA (2023))

Compound class: Synthetic organic

Comment: Adebrelimab (SHR-1316; HTI-1088) is a chimeric humanized IgG4κ anti-PD-L1 monoclonal antibody.

Bioactivity Comments
The killing effect of SHR-1316 on breast cancer cells has been demonstated in vitro [1].

Bioactivity Comments

The killing effect of SHR-1316 on breast cancer cells has been demonstated in vitro [1].

Selectivity at ligand targets

Key to terms and symbols

Click column headers to sort

Target			Sp.	Type	Action	Value	Parameter	Concentration range (M)	Reference
programmed cell death 1 ligand 1			Hs	Antibody	Binding	-	-	-
⤷